CKAP2L and central nervous system cancer: When the dataset was subdivided based on tumor grade (normal, Gr-II, Gr-III, and Gr-IV), CKAP2L mRNA expression significantly (p < 0.01) differed among groups, though no difference was detected between normal brain tissue (n = 5) and Grade II glioma (Figure 1A).